Chemical Structure : NTRC 3531-0
CAS No.: 2171408-68-5
货号: PC-49664Not For Human Use, Lab Use Only.
NTRC 3531-0 is a brain-penetrable, selective inhibitor of L-tryptophan-catabolizing enzyme tryptophan 2,3-dioxygenase (TDO) with IC50 of 490 nM (hTDO) in biochemical assays and cellular IC50 of 816 nM in HEK-hTDO.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥1580 | In stock | |
5 mg | ¥2580 | In stock | |
10 mg | ¥3980 | In stock | |
25 mg | ¥5980 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NTRC 3531-0 is a brain-penetrable, selective inhibitor of L-tryptophan-catabolizing enzyme tryptophan 2,3-dioxygenase (TDO) with IC50 of 490 nM (hTDO) in biochemical assays and cellular IC50 of 816 nM in HEK-hTDO.
NTRC 3531-0 is inactive on hIDO1 in the biochemical assay at >30 uM, inhibits Trp metabolism in human IDO1-overexpressing HEK-293 cells (HEK-hIDO1) with an IC50 of 20.7 µM, 60 times selective for hTDO over hIDO1.
NTRC 3531-0 is slightly less potent on mTDO compared to hTDO in the biochemical assays (mTDO IC50=846 nM).
Oral administration of NTRC 3531-0 (100 mg/kg) resulted in an increase in the concentration of Trp in plasma as well as in brain compared to mice treated with vehicle.
NTRC 3531-0 treatment showed decreased expression of rotenone‐induced glial fibrillary acidic protein (GFAP), which is a marker of enteric glial cells, and decreased α‐synuclein accumulation in the enteric plexus.
分子量 | 312.34 | |
分子式 | C18H17FN2O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(S)-4-(6-fluoro-1H-indol-3-yl)-N-(1-hydroxypropan-2-yl)benzamide |
1. Perez-Pardo P, et al. FEBS J. 2021 Jul;288(14):4311-4331.
2. Patent Application No. WO2018/011227 A1.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright